Notes to Consolidated Financial
Con_Note39

39   Expenditure incurred on Research and Development

( In Crore)

Particulars

For the year ended 31 March

2025

2024

     

a.

Revenue expenditure – charged to Statement of Profit and Loss

694.50

527.38

b.

Revenue expenditure – capitalised

47.54

c.

Capital expenditure – excluding building

68.71

36.89

d.

Capital expenditure – building

810.75

564.27